Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Current Assets (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Current Assets readings, the most recent being $37.5 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 48.99% to $37.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.5 million, a 48.99% increase, with the full-year FY2025 number at $37.5 million, up 48.99% from a year prior.
  • Current Assets hit $37.5 million in Q4 2025 for Lucid Diagnostics, down from $49.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $57.3 million in Q4 2021 to a low of $2.5 million in Q3 2021.
  • Median Current Assets over the past 5 years was $28.9 million (2022), compared with a mean of $32.0 million.
  • Biggest five-year swings in Current Assets: surged 3879.38% in 2021 and later plummeted 57.5% in 2022.
  • Lucid Diagnostics' Current Assets stood at $57.3 million in 2021, then plummeted by 57.5% to $24.4 million in 2022, then dropped by 9.37% to $22.1 million in 2023, then grew by 13.93% to $25.1 million in 2024, then skyrocketed by 48.99% to $37.5 million in 2025.
  • The last three reported values for Current Assets were $37.5 million (Q4 2025), $49.8 million (Q3 2025), and $33.8 million (Q2 2025) per Business Quant data.